Mersana Therapeutics, Inc. (MRSN) SEC filings
MRSN SEC filings moved a median of +0.95% by the close. MRSN SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the MRSN overview →
50 measured MRSN SEC filing events.
Where these MRSN SEC filings landedvs 44 measured MRSN SEC filing reactions
| Middle 50% of MRSN SEC filing reactions | -4.71% to +3.60% |
|---|---|
| Median reaction (to close) | +0.95% |
| Measured reactions | 44 |
Point-in-time · zero look-ahead
Half of the 44 MRSN SEC filing events with a measured close landed between -4.71% and +3.60%; 55% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 15-12G Mersana Therapeutics, | SEC filing · Form 15-12G | — | — | |
| Form EFFECT Mersana Therapeutics, | SEC filing · Form EFFECT | — | — | |
| Form 8-K Mersana Therapeutics, For: Jan 05 | SEC filing · Form 8-K | — | — | |
| Form POS AM Mersana Therapeutics, | SEC filing · Form POS | — | — | |
| Form S-8 POS Mersana Therapeutics, | SEC filing · Form S-8 | — | — | |
| Form 10-Q Mersana Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.40% | +2.61% | |
| Form 8-K Mersana Therapeutics, For: Nov 14 | SEC filing · Form 8-K | +0.40% | +2.61% | |
| Form 8-K Mersana Therapeutics, For: Nov 12 | SEC filing · Form 8-K | -2.00% | — | |
| Form 8-K Mersana Therapeutics, For: Sep 05 | SEC filing · Form 8-K | -0.59% | +3.38% | |
| Form 10-Q Mersana Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -6.43% | +21.61% | |
| Form 8-K Mersana Therapeutics, For: Aug 13 | SEC filing · Form 8-K | -6.43% | +21.61% | |
| Form 8-K Mersana Therapeutics, For: Jul 24 | SEC filing · Form 8-K | +5.07% | +0.03% | |
| Form 8-K Mersana Therapeutics, For: Jul 01 | SEC filing · Form 8-K | +2.25% | +0.56% | |
| Form 8-K Mersana Therapeutics, For: Jun 12 | SEC filing · Form 8-K | +1.48% | +8.08% | |
| Form 8-K Mersana Therapeutics, For: Jun 02 | SEC filing · Form 8-K | +3.09% | +8.85% | |
| Form 10-Q Mersana Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -6.00% | -13.98% | |
| Form 8-K Mersana Therapeutics, For: May 15 | SEC filing · Form 8-K | -6.00% | -13.98% | |
| Form 8-K Mersana Therapeutics, For: May 05 | SEC filing · Form 8-K | -6.48% | -10.76% | |
| Form ARS Mersana Therapeutics, For: Dec 31 | SEC filing · Form ARS | +3.24% | +2.61% | |
| Form DEF 14A Mersana Therapeutics, For: Jun 12 | SEC filing · Form DEF | +3.24% | +2.61% | |
| Form DEFA14A Mersana Therapeutics, | SEC filing · Form DEFA14A | +3.24% | +2.61% | |
| Form PRE 14A Mersana Therapeutics, For: Jun 12 | SEC filing · Form PRE | +0.99% | -4.69% | |
| Form 10-K Mersana Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -6.46% | -10.11% | |
| Form 8-K Mersana Therapeutics, For: Mar 03 | SEC filing · Form 8-K | -6.46% | -10.11% | |
| Form 8-K Mersana Therapeutics, For: Feb 25 | SEC filing · Form 8-K | -6.46% | -10.11% | |
| Form 8-K Mersana Therapeutics, For: Feb 05 | SEC filing · Form 8-K | +1.78% | +17.80% | |
| Form S-8 Mersana Therapeutics, | SEC filing · Form S-8 | -3.16% | +1.67% | |
| Form 8-K Mersana Therapeutics, For: Jan 10 | SEC filing · Form 8-K | -0.91% | -32.08% | |
| Form 8-K Mersana Therapeutics, For: Dec 19 | SEC filing · Form 8-K | -3.57% | -4.76% | |
| Form 10-Q Mersana Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +2.26% | -0.76% | |
| Form 8-K Mersana Therapeutics, For: Nov 13 | SEC filing · Form 8-K | +2.26% | -0.76% | |
| Form 10-Q Mersana Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +2.96% | +0.00% | |
| Form 8-K Mersana Therapeutics, For: Aug 13 | SEC filing · Form 8-K | +2.96% | +0.00% | |
| Form 8-K Mersana Therapeutics, For: Jun 11 | SEC filing · Form 8-K | +0.43% | -2.36% | |
| Form EFFECT Mersana Therapeutics, | SEC filing · Form EFFECT | +1.15% | +3.83% | |
| Form 10-Q Mersana Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -1.43% | -29.37% | |
| Form 8-K Mersana Therapeutics, For: May 09 | SEC filing · Form 8-K | -1.43% | -29.37% | |
| Form ARS Mersana Therapeutics, For: Dec 31 | SEC filing · Form ARS | -1.58% | +3.52% | |
| Form DEF 14A Mersana Therapeutics, For: Jun 11 | SEC filing · Form DEF | -1.58% | +3.52% | |
| Form DEFA14A Mersana Therapeutics, | SEC filing · Form DEFA14A | -1.58% | +3.52% | |
| Form 10-K Mersana Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +1.11% | +20.05% | |
| Form 8-K Mersana Therapeutics, For: Feb 28 | SEC filing · Form 8-K | +1.11% | +20.05% | |
| Form POS AM Mersana Therapeutics, | SEC filing · Form POS | +2.77% | -2.86% | |
| Form POSASR Mersana Therapeutics, | SEC filing · Form POSASR | +1.11% | +20.05% | |
| Form S-8 Mersana Therapeutics, | SEC filing · Form S-8 | -2.39% | -7.51% | |
| Form 8-K Mersana Therapeutics, For: Jan 05 | SEC filing · Form 8-K | -3.57% | +1.34% | |
| Form 8-K Mersana Therapeutics, For: Dec 15 | SEC filing · Form 8-K | +2.87% | +5.21% | |
| Form 10-Q Mersana Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +2.92% | -2.19% | |
| Form 8-K Mersana Therapeutics, For: Nov 07 | SEC filing · Form 8-K | +2.92% | -2.19% | |
| Form 8-K Mersana Therapeutics, For: Oct 31 | SEC filing · Form 8-K | -3.54% | +5.31% |
Keep exploring
More MRSN: earnings → · analyst actions → · MRSN overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| DOVA PHARMACEUTICALS (DOVA) | 251 | -0.10% | 46% |
| Krystal Biotech, Inc. (KRYS) | 251 | +0.05% | 52% |
| Soligenix, Inc. (SNGX) | 251 | -0.71% | 35% |
| Co-Diagnostics, Inc. (CODX) | 250 | 0.00% | 46% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.